Search Results - jonathan+vennerstrom

1 Results

Sort By:

Ozonides forms of artemisinins inhibit cytomegalovirus (CMV) replication in vitro and in vivo

INVENTION NOVELTY: This technology involves the use of a derivative of artemisinin as a new therapy for Cytomegalovirus (CMV) infection.VALUE PROPOSITION: CMV infection is recognized as a cause of morbidity and mortality, especially in immunocompromised individuals. CMV is also the most common viral infection in solid organ transplant recipients. Several...

Published: 3/13/2025 | Inventor(s): Ravit Boger, Jonathan Vennerstrom

Keywords(s): Antagonists/Inhibitors, Cytomegalovirus, Disease Indication, Dosed Therapeutic, Infectious Diseases, Novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections

Category(s): Clinical and Disease Specializations, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Infectious Diseases, Clinical and Disease Specializations > Infectious Diseases > Cytomegalovirus, Clinical and Disease Specializations > Infectious Diseases > Viral Infections